Trial Profile
A multicentre retrospective study to evaluate the injection intervals and doses used in patients who were switched from onabotulinumtoxinA to incobotulinumtoxinA
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Mar 2016
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Facial wrinkles; Glabellar lines
- Focus Therapeutic Use
- 30 Mar 2016 New trial record
- 08 Mar 2016 Results presented at the 74th Annual Meeting of the American Academy of Dermatology